Biogen Inc. (BIIB) said it delivered solid performance in the third quarter driven by continued resilience from its MS core business and growth from SPINRAZA and biosimilars. Non-GAAP earnings per share increased 24 percent from previous year. SPINRAZA revenues grew 17 percent from prior year.
from RTT - Earnings https://ift.tt/2N5EXdM
via IFTTT
No comments:
Post a Comment